TD Waterhouse Canada’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$14.6K Sell
599
-523
-47% -$12.7K ﹤0.01% 1374
2025
Q1
$22.6K Sell
1,122
-325
-22% -$6.55K ﹤0.01% 1243
2024
Q4
$34.1K Sell
1,447
-11
-0.8% -$259 ﹤0.01% 1168
2024
Q3
$36.2K Sell
1,458
-97
-6% -$2.41K ﹤0.01% 1114
2024
Q2
$36.6K Sell
1,555
-1,885
-55% -$44.3K ﹤0.01% 1089
2024
Q1
$110K Sell
3,440
-383
-10% -$12.2K ﹤0.01% 884
2023
Q4
$129K Sell
3,823
-3,619
-49% -$122K ﹤0.01% 754
2023
Q3
$215K Sell
7,442
-4,849
-39% -$140K ﹤0.01% 631
2023
Q2
$435K Sell
12,291
-2,100
-15% -$74.4K ﹤0.01% 558
2023
Q1
$440K Buy
14,391
+312
+2% +$9.54K ﹤0.01% 547
2022
Q4
$395K Sell
14,079
-5,328
-27% -$149K ﹤0.01% 559
2022
Q3
$651K Buy
19,407
+4,500
+30% +$151K 0.01% 468
2022
Q2
$474K Sell
14,907
-18,895
-56% -$601K 0.01% 546
2022
Q1
$1.64M Sell
33,802
-5,480
-14% -$266K 0.02% 372
2021
Q4
$2.44M Buy
+39,282
New +$2.44M 0.02% 339